SEC Comment Letter 0000000000-23-007362 to Adagene Inc. (ADAG)

Adagene Inc.
Date: July 11, 2023 · CIK: 0001818838 · Accession: 0000000000-23-007362

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-39997

Date

July 11, 2023

Author

Raymond Tam

Form

UPLOAD

Company

Adagene Inc.

Letter

United States securities and exchange commission logo July 11, 2023 Raymond Tam Chief Financial Officer Adagene Inc. 4F, Building C14, No. 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu Province, 215123 People’s Republic of China Re:Adagene Inc. Annual Report on Form 20-F for the fiscal year ended December 31, 2022 Filed April 28, 2023 File No. 001-39997 Dear Raymond Tam: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Xuelin Wang, Esq.

Show Raw Text

United States securities and exchange commission logo
July 11, 2023
Raymond Tam
Chief Financial Officer
Adagene Inc.
4F, Building C14, No. 218
Xinghu Street, Suzhou Industrial Park
Suzhou, Jiangsu Province, 215123
People’s Republic of China
Re:Adagene Inc.
Annual Report on Form 20-F for the fiscal year ended December 31, 2022
Filed April 28, 2023
File No. 001-39997
Dear Raymond Tam:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Xuelin Wang, Esq.

SecProbe.io